thromboembolism

(redirected from thromboembolisms)
Also found in: Thesaurus, Medical, Encyclopedia.
Related to thromboembolisms: thrombotic occlusion

throm·bo·em·bo·lism

 (thrŏm′bō-ĕm′bə-lĭz′əm)
n.
The blocking of a blood vessel by a blood clot dislodged from its site of origin.

throm′bo·em·bol′ic (-ĕm-bŏl′ĭk) adj.

thromboembolism

(ˌθrɒmbəʊˈɛmbəˌlɪzəm)
n
(Pathology) pathol the obstruction of a blood vessel by a thrombus that has become detached from its original site

throm•bo•em•bo•lism

(ˌθrɒm boʊˈɛm bəˌlɪz əm)

n.
the blockage of a blood vessel by a thrombus carried through the bloodstream.
[1905–10]
throm`bo•em•bol′ic (-ɛmˈbɒl ɪk) adj.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.thromboembolism - occlusion of a blood vessel by an embolus that has broken away from a thrombus
occlusion - closure or blockage (as of a blood vessel)
Translations

thromboembolism

n (pl -li) tromboembolia
References in periodicals archive ?
The study looked at data from 2,000 hospitals on three SCIP outcomes measures: 30-day postoperative mortality, venous thromboembolisms, and surgical site infections (Arch.
4%, but the study found little evidence of a consistent relationship between a hospital's score and its rates of risk-adjusted mortality, venous thromboembolism, or surgical site infection.
The occurrence of thromboembolisms is a serious complication in human IBD (Talbot et al 1986, Jackson et al 1996).
Both Crohn's disease and ulcerative colitis are thought to be associated with a high risk of thromboembolisms (Bernstein et al 2001).
To determine if having the Factor V Leiden genetic mutation increases the risk of thromboembolisms among women taking tamoxifen, Judy E.
Blood clots associated with those who take the pill occur in the veins of the legs and are called thromboembolisms, from which some women experience ongoing health problems, and three percent of women die.
More than 37% had at least 2 previous venous thromboembolisms, over 25% had either factor V Leiden or a prothrombin mutation, and all patients were treated with full-dose warfarin for an average of 6 months before enrollment.
An action against three pharmaceutical companies by women who had suffered thromboembolisms which they claimed were caused by third-generation oral contraceptives lost their case recently in a UK High Court.
Furthermore, individuals with combined AT deficiency and FV Leiden are likely to develop thromboembolisms earlier in life than individuals with AT deficiency alone (33).